# Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients

> **NCT01638559** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 161 (actual)

## Conditions studied

- Liver Transplant Recipients
- Liver Transplantation
- Immunosuppression

## Interventions

- **DRUG:** Immunosuppression withdrawal

## Key facts

- **NCT ID:** NCT01638559
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08-14
- **Primary completion:** 2016-03-31
- **Final completion:** 2018-06-11
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2019-10-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01638559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01638559, "Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01638559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*